Risedronate reduces postoperative bone resorption after cementless total hip arthroplasty: A systematic review and meta-analysis

The administration of risedronate was associates with a significantly improved periprosthetic BMD after primary THA. No increased risk of adverse events were observed. Higher quality RCTs are still required for further research.